GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (BSP:S1NN34) » Definitions » EV-to-FCF

Smith & Nephew (BSP:S1NN34) EV-to-FCF : 56.21 (As of Dec. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Smith & Nephew EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Smith & Nephew's Enterprise Value is R$84,701 Mil. Smith & Nephew's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was R$1,507 Mil. Therefore, Smith & Nephew's EV-to-FCF for today is 56.21.

The historical rank and industry rank for Smith & Nephew's EV-to-FCF or its related term are showing as below:

BSP:S1NN34' s EV-to-FCF Range Over the Past 10 Years
Min: 21.95   Med: 34.88   Max: 150
Current: 46.27

During the past 13 years, the highest EV-to-FCF of Smith & Nephew was 150.00. The lowest was 21.95. And the median was 34.88.

BSP:S1NN34's EV-to-FCF is ranked worse than
66.58% of 374 companies
in the Medical Devices & Instruments industry
Industry Median: 28.735 vs BSP:S1NN34: 46.27

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-14), Smith & Nephew's stock price is R$29.13. Smith & Nephew's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was R$0.732. Therefore, Smith & Nephew's PE Ratio (TTM) for today is 39.80.


Smith & Nephew EV-to-FCF Historical Data

The historical data trend for Smith & Nephew's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew EV-to-FCF Chart

Smith & Nephew Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.30 40.10 36.58 129.83 81.13

Smith & Nephew Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 129.83 - 81.13 -

Competitive Comparison of Smith & Nephew's EV-to-FCF

For the Medical Devices subindustry, Smith & Nephew's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smith & Nephew's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's EV-to-FCF falls into.



Smith & Nephew EV-to-FCF Calculation

Smith & Nephew's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=84701.444/1506.936
=56.21

Smith & Nephew's current Enterprise Value is R$84,701 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Smith & Nephew's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was R$1,507 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smith & Nephew  (BSP:S1NN34) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Smith & Nephew's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=29.13/0.732
=39.80

Smith & Nephew's share price for today is R$29.13.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Smith & Nephew's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was R$0.732.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Smith & Nephew EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Smith & Nephew Business Description

Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Headlines

No Headlines